Location History:
- Yokohama, JP (2007)
- Shizuoka, JP (2010)
Company Filing History:
Years Active: 2007-2010
Title: Innovations of Katsura Kaneko
Introduction
Katsura Kaneko is a notable inventor based in Shizuoka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolide compounds and pipecolamide derivatives. With a total of two patents to her name, her work showcases innovative methods that have potential applications in antitumor treatments.
Latest Patents
One of her latest patents is a method of producing a macrolide compound. This invention provides a novel approach to producing the 12-membered ring macrolide compound 11107D, which exhibits antitumor activity through biological transformation. The process involves incubating the starting material, the 12-membered ring macrolide compound 11107B, in the presence of specific strains from the Micromonosporaceae family. The target substance, 11107D, is then collected from the treating solution.
Another significant patent is a method for producing a pipecolamide derivative. This method involves reacting pipecolic acid or its acid salt with an amine in an inert solvent, utilizing a condensing agent. This innovative approach allows for the efficient and economical manufacturing of pipecolamide derivatives, particularly in their optically active forms, without generating harmful gas by-products.
Career Highlights
Katsura Kaneko has worked with reputable companies such as Mercian Corporation and Eisai R&D Management Co., Ltd. Her experience in these organizations has contributed to her expertise in pharmaceutical research and development.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Akifumi Okuda and Satoshi Yamamoto. These partnerships have likely enhanced her research capabilities and innovation potential.
Conclusion
Katsura Kaneko's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a significant inventor. Her work continues to influence the development of important therapeutic compounds.